Publications
  • 25. Zhang, X.; Chen, D.; Zhao, M.; Zhao, J.*; Jia, A.;* Li, X. * “Synthesis of Isoquinolines via Rhodium(III)-Catalyzed Dehydrative C-C and C-N Coupling between Oximines and Alkynes” Adv. Synth. Catal. 2011, 719-723.
  • 24. Tao, C.;* Lv, A.; Zhao, N.; Yang, S.; Liu, X.; Zhou, J.; Liu, W.; Zhao, J.* “Ligand-Free Copper-Catalyzed Synthesis of Diaryl Thioethers from Aryl Halides and Thioacetamide” Synlett, 2011, 134-138.
  • 23. Qian, Y.; Ma, G.; Yang, Y.; Cheng, K.; Zheng, Q.-Z.; Mao, W.-J.; Shi, L.; Zhao, J.*; Zhu, H.-L.* “Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents” Bioorg. Med. Chem., 2010, 18, 4310-4316.
  • 22. Qian, Y.; Zhang, H.; Zhang, H.; Xu, C.*; Zhao, J.*; Zhu, H.-L.* “Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents” Bioorg. Med. Chem., 2010, 18, 4991-4996.
  • 21. Tao, C.*; Liu, W.; Lv, A.; Sun, M.; Tian, Y.; Wang, Q.; Zhao, J.* “Room-Temperature Copper-Catalyzed Synthesis of Primary Arylamines from Aryl Halides and Aqueous Ammonia” Synlett, 2010, 9, 1355-1358.
  • 20. Cheng, K.; Zheng, Q.-Z.; Hou, J.; Zhou, Y.; Liu, C.H.; Zhao, J.*; Zhu, H.-L.* “Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics” Bioorg. Med. Chem., 2010, 18, 2447-2455.
  • 19. Qian, Y.; Ma, G.; Lv, A.; Zhu, H.-L.; Zhao, J.*; Rawal, V. H.* “Squaramide-Catalyzed Enantioselective Friedel-Crafts Reaction of Indoles with Imines”, Chem. Comm. 2010, 46, 3004-3006.
  • 18. Zhao, T. X.; Martinko, A. J.; Le, V. H.; Zhao, J.; Yin, H.* “Development of Agents That Modulate Protein-Protein Interactions in Membranes”, Curr. Pharm. Design, 2010, 16, 1055-1062.
  • 17. Cheng, K.; Zheng, Q.-Z.; Qian, Y.; Shi, L.; Zhao, J.*; Zhu, H.-L.* “Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics” Bioorg.Med.Chem. 2009,17,7861-7871.
  • 16. Li, H.; Shi, L.; Li, Q.; Liu, P.; Luo, Y.; Zhao, J., Zhu, H-L.* “Synthesis of C(7) modified chrysin derivatives designing to inhibit b-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics”, Bioorg. Med. Chem., 2009, 6264-6269.